These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12798954)

  • 21. The effect of isoproterenol on the class III effect of azimilide in humans.
    Dorian P; Dunnmon P; Elstun L; Newman D
    J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):211-7. PubMed ID: 12490966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
    Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
    Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological block of the slow component of the outward delayed rectifier current (I(Ks)) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration.
    Lengyel C; Iost N; Virág L; Varró A; Lathrop DA; Papp JG
    Br J Pharmacol; 2001 Jan; 132(1):101-10. PubMed ID: 11156566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The class III effect of azimilide is not associated with reverse use-dependence in open-chest dogs.
    Qi XQ; Newman D; Dorian P
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):898-903. PubMed ID: 10598136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall.
    Yan GX; Wu Y; Liu T; Wang J; Marinchak RA; Kowey PR
    Circulation; 2001 Jun; 103(23):2851-6. PubMed ID: 11401944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.
    Baczkó I; El-Reyani NE; Farkas A; Virág L; Iost N; Leprán I; Mátyus P; Varró A; Papp JG
    Eur J Pharmacol; 2000 Sep; 404(1-2):181-90. PubMed ID: 10980278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the effects of urinary incontinence agents S-oxybutynin and terodiline on cardiac K(+) currents and action potentials.
    Jones SE; Shuba LM; Zhabyeyev P; McCullough JR; McDonald TF
    Br J Pharmacol; 2000 Sep; 131(2):245-54. PubMed ID: 10991917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of azimilide with neurohumoral and channel receptors.
    Brooks RR; Pong SF; Izzo NJ; Moorehead TJ; Gopalakrishnan M; Triggle DJ
    Biochem Pharmacol; 2001 Oct; 62(7):883-92. PubMed ID: 11543723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac electrophysiological modulation by NS-7, a novel neuroprotective drug, of guinea pig ventricular muscles.
    Satoh H
    Life Sci; 2003 Jan; 72(9):1039-48. PubMed ID: 12495782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
    Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA
    Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of thymol on calcium and potassium currents in canine and human ventricular cardiomyocytes.
    Magyar J; Szentandrássy N; Bányász T; Fülöp L; Varró A; Nánási PP
    Br J Pharmacol; 2002 May; 136(2):330-8. PubMed ID: 12010783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choice of cardiac tissue in vitro plays an important role in assessing the risk of drug-induced cardiac arrhythmias in human: beyond QT prolongation.
    Lu HR; Vlaminckx E; Gallacher DJ
    J Pharmacol Toxicol Methods; 2008; 57(1):1-8. PubMed ID: 17964190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
    Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
    Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of articaine on action potential characteristics and the underlying ion currents in canine ventricular myocytes.
    Szabó A; Szentandrássy N; Birinyi P; Horváth B; Szabó G; Bányász T; Márton I; Nánási PP; Magyar J
    Br J Anaesth; 2007 Nov; 99(5):726-33. PubMed ID: 17895236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological effects of haloperidol on isolated rabbit Purkinje fibers and guinea pigs papillary muscles under normal and simulated ischemia.
    Yan D; Cheng LF; Song HY; Turdi S; Kerram P
    Acta Pharmacol Sin; 2007 Aug; 28(8):1155-60. PubMed ID: 17640477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action potentials, contraction, and membrane currents in guinea pig ventricular preparations treated with the antispasmodic agent terodiline.
    Shuba LM; Kasamaki Y; Jones SE; Ogura T; McCullough JR; McDonald TF
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1417-26. PubMed ID: 10454521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological effects of risperidone in mammalian cardiac cells.
    Magyar J; Bányász T; Bagi Z; Pacher P; Szentandrássy N; Fülöp L; Kecskeméti V; Nánási PP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):350-6. PubMed ID: 12237749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can the electrophysiological action of rosiglitazone explain its cardiac side effects?
    Szebeni A; Szentandrássy N; Pacher P; Simkó J; Nánási PP; Kecskeméti V
    Curr Med Chem; 2011; 18(24):3720-8. PubMed ID: 21774756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations.
    Szél T; Koncz I; Jost N; Baczkó I; Husti Z; Virág L; Bussek A; Wettwer E; Ravens U; Papp JG; Varró A
    Eur J Pharmacol; 2011 Jul; 662(1-3):31-9. PubMed ID: 21550338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval.
    Drolet B; Khalifa M; Daleau P; Hamelin BA; Turgeon J
    Circulation; 1998 Jan; 97(2):204-10. PubMed ID: 9445174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.